Curanex Pharmaceuticals Inc (CURX)
NCM · Healthcare · Biotechnology
$0.32
-4.75%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$9.1M
Shares Outstanding
28.3M
Exchange
NCM
Currency
USD
About Curanex Pharmaceuticals Inc
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -58K | -951K | -3.1M | -3.2M |
| Net Income | -60K | -954K | -3.1M | -3.2M |
| Diluted EPS | $-0.00 | $-0.04 | $nan | $-0.11 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 26K | 0.00 | 0.00 | 0.00 |
| Gross Profit | 4K | 0.00 | ||
| Operating Income | -20K | -19K | -290K | -4.2M |
| Net Income | -20K | -19K | -362K | -4.2M |
| Diluted EPS | $-0.02 | $-0.00 | $-0.01 | $-0.17 |